Tuesday, June 23, 2026

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,771
Drugs linked 4,798

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 585 of 1,261
  1. US 9878031

    Compositions, methods of administration and uses for trivalent dengue virus formulations

    Takeda Vaccines, Inc. · Granted Jan 30, 2018 · Expires Jan 25, 2038

    granted
  2. US 9878972

    Compounds and methods for delivery of prostacyclin analogs

    United Therapeutics Corporation · Granted Jan 30, 2018 · Expires Jan 25, 2038

    granted
  3. US 9877952

    Methods for dosing an orally active 1,2,4-oxadiazole for nonsense mutation suppression therapy

    PTC THERAPEUTICS, INC. · Granted Jan 30, 2018 · Expires Jan 25, 2038

    granted
  4. US 9873677

    Pharmaceutical compositions and salts of a 1,2,4-oxadiazole benzoic acid

    PTC THERAPEUTICS, INC. · Granted Jan 23, 2018 · Expires Jan 18, 2038

    granted
  5. US 9872855

    (2R,4R)-5-(5′-Chloro-2′-fluorobiphenyl-4-yl)-2-hydroxy-4-[(5-methyloxazole-2-carbonyl)amino]pentanoic acid

    Theravance Biopharma R&D IP, LLC · Granted Jan 23, 2018 · Expires Jan 18, 2038

    granted
  6. US 9873893

    Methods and compositions for treating genetically linked diseases of the eye

    The United States of America as Represented by the Secretary, Dept. of Health and Human Services · Granted Jan 23, 2018 · Expires Jan 18, 2038

    granted
  7. US 9873696

    Neprilysin inhibitors

    Theravance Biopharma R&D IP, LLC · Granted Jan 23, 2018 · Expires Jan 18, 2038

    granted
  8. US 9872909

    Method for enhancing specific immunotherapies in cancer treatment

    Providence Health & Services—Oregon · Granted Jan 23, 2018 · Expires Jan 18, 2038

    granted
  9. US 9873875

    Methods and compositions for the specific inhibition of gene expression by double-stranded RNA

    INTEGRATED DNA TECHNOLOGIES, INC. · Granted Jan 23, 2018 · Expires Jan 18, 2038

    granted
  10. US 9872850

    Compositions and methods for improving mitochondrial function and treating neurodegenerative diseases and cognitive disorders

    Amazentis SA · Granted Jan 23, 2018 · Expires Jan 18, 2038

    granted
  11. US 9872926

    Multicolored pH-activatable fluorescence nanoplatform

    The Board of Regents of the University of Texas System · Granted Jan 23, 2018 · Expires Jan 18, 2038

    granted
  12. US 9873722

    Wnt compositions and therapeutic uses of such compositions

    Fate Therapeutics, Inc. · Granted Jan 23, 2018 · Expires Jan 18, 2038

    granted
  13. US 9873867

    Manufacture of active highly phosphorylated human lysosomal sulfatase enzymes and uses thereof

    BIOMARIN PHARMACEUTICAL INC. · Granted Jan 23, 2018 · Expires Jan 18, 2038

    granted
  14. US 9873718

    Structure-based peptide inhibitors of P53 aggregation as a new approach to cancer therapeutics

    The Regents of the University of California · Granted Jan 23, 2018 · Expires Jan 18, 2038

    granted
  15. US 9873702

    Heterocyclic compounds as biogenic amine transport modulators

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jan 23, 2018 · Expires Jan 18, 2038

    granted
  16. US 9873876

    Cancer treatment

    Ionis Pharmaceuticals, Inc. · Granted Jan 23, 2018 · Expires Jan 18, 2038

    granted
  17. US 9873685

    Neprilysin inhibitors

    Theravance Biopharma R&D IP, LLC · Granted Jan 23, 2018 · Expires Jan 18, 2038

    granted
  18. US 9873964

    Dispersible non-woven fabrics

    LENZING AKTIENGESELLSCHAFT · Granted Jan 23, 2018 · Expires Jan 18, 2038

    granted
  19. US 9873692

    Quinolinone-carboxamide compounds as 5-HT4 receptor agonists

    Theravance Biopharma R&D IP, LLC · Granted Jan 23, 2018 · Expires Jan 18, 2038

    granted
  20. US 9872953

    Nitric oxide delivery devices

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Jan 23, 2018 · Expires Jan 18, 2038

    granted
  21. US 9872912

    Method for treating pancreatic cancer

    China Medical University · Granted Jan 23, 2018 · Expires Jan 18, 2038

    granted
  22. US 9872865

    Compositions for improving cell viability and methods of use thereof

    Amylyx Pharmaceuticals, Inc. · Granted Jan 23, 2018 · Expires Jan 18, 2038

    granted
  23. US 9872935

    Hydrogel implants with varying degrees of crosslinking

    Covidien LP · Granted Jan 23, 2018 · Expires Jan 18, 2038

    granted
  24. US 9872918

    Hydroxyl-polymer-drug-protein conjugates

    Mersana Therapeutics, Inc. · Granted Jan 23, 2018 · Expires Jan 18, 2038

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.